Serlopitant: Phase II data

Top-line data from a double-blind, U.S. Phase II trial in 257 patients ages 18-65 with chronic pruritus and a VAS

Read the full 205 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE